Literature DB >> 19061179

Effects of radiation on the NMR relaxation effects of aqueous solutions of gadolinium contrast agents.

David H Gultekin1, Thomas E Raidy, John C Gore.   

Abstract

We investigate the effects of radiation on aqueous solutions of two common MRI contrast agents based on paramagnetic gadolinium chelates. Aqueous solutions of Gd-DTPA (gadolinium diethylenetriaminepentaacetic acid) and Gd-HP-DO3A (gadoteridol), as well as Gd-DTPA in the presence of concentrations of several common metabolites (N-acetylaspartate, Choline, Creatine and myo-inositol) typical of conditions in vivo, were irradiated at dose levels up to 30 Gy using a 6 MV linear accelerator and imaged using a 1.5 T MRI system. In addition, the effects of radiation dose on solution relaxation rates were compared with the effects of temperature by subjecting the same samples to varying temperatures over a range of 4 K using the same experimental conditions and imaging sequences. Radiation caused small increases (1% or less at a dose of 20 Gy) in the relaxivity of solutions. The effects of radiation on relaxivities were orders of magnitude smaller than the effects of temperature over the range in this study. Copyright 2008 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19061179      PMCID: PMC2669830          DOI: 10.1002/cmmi.259

Source DB:  PubMed          Journal:  Contrast Media Mol Imaging        ISSN: 1555-4309            Impact factor:   3.161


  8 in total

Review 1.  Safety of magnetic resonance imaging contrast agents.

Authors:  F G Shellock; E Kanal
Journal:  J Magn Reson Imaging       Date:  1999-09       Impact factor: 4.813

Review 2.  Physicochemical properties of gadoteridol and other magnetic resonance contrast agents.

Authors:  M F Tweedle
Journal:  Invest Radiol       Date:  1992-08       Impact factor: 6.016

3.  Temperature dependence of nuclear magnetization and relaxation.

Authors:  David H Gultekin; John C Gore
Journal:  J Magn Reson       Date:  2005-01       Impact factor: 2.229

4.  Measurement of heat transfer coefficients by nuclear magnetic resonance.

Authors:  David H Gultekin; John C Gore
Journal:  Magn Reson Imaging       Date:  2008-06-03       Impact factor: 2.546

5.  RARE imaging: a fast imaging method for clinical MR.

Authors:  J Hennig; A Nauerth; H Friedburg
Journal:  Magn Reson Med       Date:  1986-12       Impact factor: 4.668

6.  Signal modulation in (1)H magnetic resonance spectroscopy using contrast agents: proton relaxivities of choline, creatine, and N-acetylaspartate.

Authors:  P S Murphy; M O Leach; I J Rowland
Journal:  Magn Reson Med       Date:  1999-12       Impact factor: 4.668

Review 7.  Extracellular gadolinium contrast agents: differences in stability.

Authors:  S K Morcos
Journal:  Eur J Radiol       Date:  2008-03-14       Impact factor: 3.528

8.  Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent.

Authors:  H J Weinmann; R C Brasch; W R Press; G E Wesbey
Journal:  AJR Am J Roentgenol       Date:  1984-03       Impact factor: 3.959

  8 in total
  3 in total

1.  Stability of MRI contrast agents in high-energy radiation of a 1.5T MR-Linac.

Authors:  Jihong Wang; Travis Salzillo; Yongying Jiang; Yuri Mackeyev; Clifton David Fuller; Caroline Chung; Seungtaek Choi; Neil Hughes; Yao Ding; Jinzhong Yang; Sastry Vedam; Sunil Krishnan
Journal:  Radiother Oncol       Date:  2021-06-03       Impact factor: 6.901

2.  Safety of gadolinium based contrast agents in magnetic resonance imaging-guided radiotherapy - An investigation of chelate stability using relaxometry.

Authors:  Faisal Mahmood; Ulla Gro Nielsen; Christian Brandt Jørgensen; Carsten Brink; Henrik S Thomsen; Rasmus Hvass Hansen
Journal:  Phys Imaging Radiat Oncol       Date:  2022-02-26

Review 3.  MR-Guided Adaptive Radiotherapy for OAR Sparing in Head and Neck Cancers.

Authors:  Samuel L Mulder; Jolien Heukelom; Brigid A McDonald; Lisanne Van Dijk; Kareem A Wahid; Keith Sanders; Travis C Salzillo; Mehdi Hemmati; Andrew Schaefer; Clifton D Fuller
Journal:  Cancers (Basel)       Date:  2022-04-10       Impact factor: 6.575

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.